142 related articles for article (PubMed ID: 9727773)
1. High incidence of primary pulmonary hypertension associated with appetite suppressants in Belgium.
Delcroix M; Kurz X; Walckiers D; Demedts M; Naeije R
Eur Respir J; 1998 Aug; 12(2):271-6. PubMed ID: 9727773
[TBL] [Abstract][Full Text] [Related]
2. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.
Abenhaim L; Moride Y; Brenot F; Rich S; Benichou J; Kurz X; Higenbottam T; Oakley C; Wouters E; Aubier M; Simonneau G; Bégaud B
N Engl J Med; 1996 Aug; 335(9):609-16. PubMed ID: 8692238
[TBL] [Abstract][Full Text] [Related]
3. Appetite suppressants and primary pulmonary hypertension in the United Kingdom.
Thomas SH; Butt AY; Corris PA; Egan JJ; Higenbottam TW; Madden BP; Waller PC
Br Heart J; 1995 Dec; 74(6):660-3. PubMed ID: 8541174
[TBL] [Abstract][Full Text] [Related]
4. Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension.
Rich S; Rubin L; Walker AM; Schneeweiss S; Abenhaim L
Chest; 2000 Mar; 117(3):870-4. PubMed ID: 10713017
[TBL] [Abstract][Full Text] [Related]
5. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation.
Jick H; Vasilakis C; Weinrauch LA; Meier CR; Jick SS; Derby LE
N Engl J Med; 1998 Sep; 339(11):719-24. PubMed ID: 9731087
[TBL] [Abstract][Full Text] [Related]
6. Appetite-suppressant drugs and the risk of primary pulmonary hypertension?
Deitel M
Obes Surg; 1997 Feb; 7(1):3-4. PubMed ID: 9730529
[No Abstract] [Full Text] [Related]
7. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases.
Souza R; Humbert M; Sztrymf B; Jaïs X; Yaïci A; Le Pavec J; Parent F; Hervé P; Soubrier F; Sitbon O; Simonneau G
Eur Respir J; 2008 Feb; 31(2):343-8. PubMed ID: 17959632
[TBL] [Abstract][Full Text] [Related]
8. Appetite suppressants and pulmonary hypertension: a long-term risk.
Prescrire Int; 2006 Oct; 15(85):183. PubMed ID: 17131516
[No Abstract] [Full Text] [Related]
9. [Appetite depressant drugs and the risk of primary pulmonary hypertension].
Olschewski H
Pneumologie; 1997 Jun; 51(6):575-6. PubMed ID: 9333790
[No Abstract] [Full Text] [Related]
10. Primary pulmonary hypertension and long-term use of appetite suppressants.
Sztuke-Fournier A
CMAJ; 1997 Jan; 156(1):89-90, 93-4. PubMed ID: 9006574
[No Abstract] [Full Text] [Related]
11. Fenfluramines, idiopathic pulmonary primary hypertension and cardiac valve disorders: facts and artifacts.
Tellier P
Ann Med Interne (Paris); 2001 Nov; 152(7):429-36. PubMed ID: 11965083
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of fenfluramine-related aortic regurgitation in women with end-stage renal disease secondary to Chinese herb nephropathy.
Unger P; Nortier J; Muniz Martinez MC; Plein D; Vandenbossche JL; Vereerstraeten P; Vanherweghem JL
Nephrol Dial Transplant; 2003 May; 18(5):906-10. PubMed ID: 12686663
[TBL] [Abstract][Full Text] [Related]
13. Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence.
McCann UD; Seiden LS; Rubin LJ; Ricaurte GA
JAMA; 1997 Aug; 278(8):666-72. PubMed ID: 9272900
[TBL] [Abstract][Full Text] [Related]
14. [Iatrogenic pulmonary artery hypertension].
Weitzenblum E; Kessler R; Chaouat A
Rev Mal Respir; 1996; 13(2):133-9. PubMed ID: 8711232
[TBL] [Abstract][Full Text] [Related]
15. Primary pulmonary hypertension associated with the use of fenfluramine derivatives.
Simonneau G; Fartoukh M; Sitbon O; Humbert M; Jagot JL; Hervé P
Chest; 1998 Sep; 114(3 Suppl):195S-199S. PubMed ID: 9741568
[TBL] [Abstract][Full Text] [Related]
16. [Appetite suppressants and heart valve disorders].
Adams C; Cohen A
Arch Mal Coeur Vaiss; 1999 Sep; 92(9):1213-9. PubMed ID: 10533670
[TBL] [Abstract][Full Text] [Related]
17. Dangers of certain appetite suppressants.
Prime FJ
Br Med J; 1969 Jul; 3(5663):177. PubMed ID: 5792926
[No Abstract] [Full Text] [Related]
18. Appetite-suppressant drugs and primary pulmonary hypertension.
Fishman AP
N Engl J Med; 1997 Feb; 336(7):511; author reply 512-3. PubMed ID: 9019650
[No Abstract] [Full Text] [Related]
19. BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives.
Humbert M; Deng Z; Simonneau G; Barst RJ; Sitbon O; Wolf M; Cuervo N; Moore KJ; Hodge SE; Knowles JA; Morse JH
Eur Respir J; 2002 Sep; 20(3):518-23. PubMed ID: 12358323
[TBL] [Abstract][Full Text] [Related]
20. [Drug-clinics. The hue and cry over central appetite suppressants!].
Scheen AJ
Rev Med Liege; 1997 Sep; 52(9):613-5. PubMed ID: 9441348
[No Abstract] [Full Text] [Related]
[Next] [New Search]
